Regulatory Hurdles for Increased Availability of Cannabis-Infused Edibles

Published

 

Merril Gilbert, founder and CEO of TraceTrust: One is getting it declassified as a Schedule I narcotic. It’s clearly not that. There is no addictive qualities: it’s a combination of other things. But it’s also, again, how do I counteract it and not knowing how it’s going to react for different people. You’re going to have the same reaction as if you have a peanut allergy and we have to be really conscious of that. So, again, creating a standard like we’re doing in this same manner and together with other types of certifications –nonGMO and vegan– and really aligning together, raising up together and not competing against each other is crucial now.

0 Comments

For advertising opportunities:

John Hydrusko, Vice President
(609) 716-7777 x 223
jhydrusko@pharmacytimes.com

Molly Higgins, National Accounts Associate
(609) 325-4837
mhiggins@totalpharmacy.com

For editorial questions:

Davy James, Managing Editor
(609) 716-7777 x 236
djames@totalpharmacy.com

Jennifer Barrett, Associate Editor
(609) 716-7777 x 839
jbarrett@totalpharmacy.com

Powered by Medstro